Combination of ATRAP deletion and angiotensin II accelerates DKD progression, which may also accelerate DKD research

Hypertens Res. 2024 Dec 19. doi: 10.1038/s41440-024-02069-9. Online ahead of print.

Authors

Daisuke Fujimoto¹, Takashige Kuwabara²

Affiliations

¹ Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
² Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan. [email protected].

PMID: 39702773
DOI: 10.1038/s41440-024-02069-9

No abstract available

Keywords: ATRAP; Angiotensin II; Diabetic kidney disease.

Publication types

Editorial
Comment